TABLE 2.
Baicalein enhances the antimicrobial activity of doxycycline against Gram-negative pathogens
| Strain | Genotypea | Resistance pattern | Doxycycline |
Baicalein |
FICIb | ||
|---|---|---|---|---|---|---|---|
| MIC (μg/mL) | FIC | MIC (μg/mL) | FIC | ||||
| A. baumannii | |||||||
| AB9 | tetA+ tetB+ | MDR | 128 | 0.0625 | 250 | 0.25 | 0.3125 |
| AB24 | tetB + | PDR | 128 | 0.125 | 500 | 0.25 | 0.375 |
| AB27 | tetA+ tetB+ | MDR | 128 | 0.03125 | 250 | 0.125 | 0.15625 |
| AB32 | tetA+ tetB+ | PDR | 128 | 0.25 | 250 | 0.25 | 0.5 |
| AB43 | tetA tetB | Sensitive | 1 | 0.25 | 250 | 0.125 | 0.375 |
| AB145 | tetA + | MDR | 128 | 0.03125 | 250 | 0.0625 | 0.09375 |
| AB146 | tetB+ | PDR | 128 | 0.25 | 250 | 0.125 | 0.375 |
| AB151 | tetA tetB | PDR | 64 | 0.125 | 500 | 0.125 | 0.25 |
| AB152 | tetA+ tetB+ | MDR | 64 | 0.03125 | 500 | 0.25 | 0.28125 |
| ATCC 19606 | tetA tetB | Type strain, non-MDR | 1 | 0.25 | 250 | 0.25 | 0.5 |
| K. pneumoniae | |||||||
| KP1 | tetA + | MDR | 128 | 0.125 | 250 | 0.0625 | 0.1875 |
| KP2 | tetA + | PDR | 128 | 0.25 | 500 | 0.125 | 0.375 |
| KP6 | tetA + | PDR | 64 | 0.125 | 500 | 0.25 | 0.375 |
| KP10 | tetA + | MDR | 64 | 0.0625 | 125 | 0.125 | 0.1875 |
| KP12 | tetA + | MDR | 64 | 0.03125 | 250 | 0.25 | 0.28125 |
| KP13 | tetA + | PDR | 64 | 0.0625 | 500 | 0.25 | 0.3125 |
| KP14 | tetA + | PDR | 32 | 0.125 | 500 | 0.25 | 0.375 |
| KP15 | tetA + | MDR | 32 | 0.125 | 250 | 0.125 | 0.25 |
| E. coli | |||||||
| E.col-1 | tetA + | MDR | 32 | 0.125 | 250 | 0.25 | 0.375 |
| E.col-2 | tetA + | MDR | 64 | 0.0625 | 500 | 0.0625 | 0.125 |
| E.col-3 | tetA + | MDR | 32 | 0.125 | 250 | 0.125 | 0.25 |
| P. aeruginosa | |||||||
| PA-1 | tetA + | MDR | 64 | 0.125 | 250 | 0.125 | 0.25 |
| PA-2 | tetA + | MDR | 128 | 0.125 | 500 | 0.125 | 0.25 |
+, presence; no symbol, absence.
The FICI is the sum of the FICs of doxycycline and baicalein. All effects shown here are defined as synergistic (FICI ≤ 0.5).